Intravenous Solutions Market: Single-Dose Amino Acid Solution Segment Held The Largest Revenue Share

 Intravenous Solutions Industry Overview

The global intravenous solutions market size was valued at USD 11.1 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 8.0% over the forecast period. This is due to a rise in natality rate, an increasing geriatric population, a growing prevalence of cancer, and a rise in the prevalence of malnutrition. The COVID-19 pandemic has significantly increased the production of intravenous (IV) solutions. In the ongoing fight against COVID-19, Intensive Care Units (ICUs) are filled with patients infected by COVID-19. The demand for intravenous injections has increased during the pandemic.

Also, the new coronavirus strains have been reported in various parts of the world leading to more people suffering from the virus. As a result, an increase in the number of hospital admissions is also witnessed. Many patients, particularly the elderly and patients with severe lung infections, are put on ventilators for critical care. In such cases, to maintain adequate nutrition, intravenous solutions are constantly provided to such patients. Furthermore, the WHO recommends that patients with COVID-19 having severe respiratory infections should be treated with intravenous fluids. As a result, the demand for IV solutions is projected to increase significantly, particularly during the pandemic.


Gather more insights about the market drivers, restrains and growth of the Global Intravenous Solutions market

 

In addition, breakthroughs in surgical operations and therapies have enhanced life expectancy, resulting in a significant demand for modern medical care. IV nutrition is a crucial aspect of any treatment to help patients meet their nutritional needs and recover faster. When patients are unable to accept nutritional solutions administered by the enteral or oral routes, the Total Parenteral Nutrition (TPN) approach is used. The regulations for the production of large and small volume parenteral utilized in TPN are outlined in FDA Code of Federal Relations Section 201.323.

The increasing prevalence of chronic conditions, such as cancer, boosts the demand for parenteral nutrition across the country. Parenteral nutrition provides vital nutrients that help in maintaining the strength, energy, and hydration of patients suffering from chronic diseases. According to the statistics published by the WHO, approximately 10 million deaths are recorded in 2020 from cancer. Moreover, a 70.0% increase in cancer cases is anticipated over the next couple of decades. The increasing prevalence of cancer is expected to aid in the growth of the market.



Browse through Grand View Research's Medical Devices Industry Research Reports.

  • Atrial Fibrillation Market - The global atrial fibrillation market size was valued at USD 22.4 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 10.1% from 2023 to 2030. The increasing prevalence of atrial fibrillation (AFib) and growing awareness about the condition are expected to drive the market.

 

  • Sperm Bank Market - The global sperm bank market size was valued at USD 5.0 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 3.56% over the forecast period from 2023 to 2030. Innovations in cryopreservation techniques, rising awareness, the emergence of fertility tourism, and increasing access to infertility treatment are the key factors driving the growth.

 

Intravenous Solutions Market Segmentation

Grand View Research has segmented the intravenous solutions market based on product, nutrients, and region:

Intravenous Solutions Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Total Parenteral Nutrition
  • Peripheral Parenteral Nutrition

Intravenous Solutions Nutrients Outlook (Revenue, USD Million, 2018 - 2030)

  • Carbohydrates
  • Vitamins and Minerals
  • Single Dose Amino Acids
  • Parenteral Lipid Emulsion
  • Others

Intravenous Solutions Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

 

Market Share Insights:

  • January 2022: ICU Medical acquired a subsidiary of Smiths Group plc that is Smiths Medical. This acquisition will combine the ambulatory infusion devices, syringe, vascular access, and vital care products of Smiths Medical into the existing infusion therapy system of ICU Medical and create an estimated pro forma revenue of approximately USD 2.5 billion.

 

Key Companies profiled:

Some of the prominent players in the global intravenous solutions market include:

  • Fresenius Kabi AG
  • Pfizer, Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Baxter
  • Braun Melsungen AG
  • Vifor Pharma Management Ltd.
  • JW Life Science
  • Amanta Healthcare
  • ICU Medical Inc.
  • Grifols, S.A.

 

Order a free sample PDF of the Intravenous Solutions Market Intelligence Study, published by Grand View Research.


About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.


Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

 

Comments

Post a Comment

Popular posts from this blog

Drug Addiction - Pipeline Review, H1 2017 Market Overview and trends research report

Radiant insights, inc latest Pharmaceutical and Healthcare disease pipeline guide Drug Addiction - Pipeline Review, H1 2017, provides an overview of the Drug Addiction (Central Nervous System) pipeline landscape. Drug addiction, also called substance dependence or chemical dependency, is a disease that is characterized by a destructive pattern of drug abuse that leads to significant problems involving tolerance to or withdrawal from the substance. Drug addiction symptoms or behaviors include recurrent drug use that results in a lack of meeting important obligations at work, school, or home, inability to sleep, awake at unusual times, unusual laziness, loss of or increased in appetite, changes in eating habits, cold, sweaty palms; shaking hands., red, watery eyes; pupils larger or smaller than usual and unusual smells on breath, body or clothes. Report Highlights Radiant insights, inc Pharmaceutical and Healthcare latest pipeline guide Drug Addiction - Pipeline Review, H1 2017, p...
Read more

All Countries Dialyzer Industry 2013-2028 - Market Size, Share, Outlook, Growth, Key Players and Forecast

The global Dialyzer market was valued at $XX million in 2018, and Radiant Insights, Inc analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Dialyzer from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Dialyzer market. Download Free Sample Report @ https://www.radiantinsights.com/research/2013-2028-report-on-global-dialyzer-market/request-sample Leading players of Dialyzer including: • Fresenius Medical Care • Baxter • Nipro • Asahi Kasei • Toray • B.Braun • Nikkiso • Medtronic • Kawasumi • Medica • Wego • Lengthen • Peony Medical • Chengdu OCI • Bain Medical Equipment Market split by Type, can be divided into: • Flat Type Dialyzer • Coil Tube Dialyzer • Ho...
Read more

Insights into the Medical Waste Disposal Category: A Comprehensive Procurement Intelligence Report

  Medical Waste Disposal Category Overview The medical waste disposal category is anticipated to grow at a CAGR of 6.0% from 2023 to 2030. Appropriate disposal of medical trash is the key challenge for healthcare providers across the globe. Rising awareness about the benefits of proper medical waste management for treatment, recycling, and disposal of medical trash has boosted the growth of the category. According to the World Health Organization Study Report 2022, countries with low income generate over 0.2 kg of medical trash per day per hospital bed, whereas countries with high income generate hazardous waste of up to 0.5 kg per hospital bed each day. Moreover, rising government initiatives and strict rules and regulations for waste management are also expected to drive the category. For instance, in December 2022, an MOU was signed between the Center for Health Environment Research and Development and Can Tho Central General Hospital under USAID’s Reducing Pollution Project. T...
Read more